AN2 Therapeutics Inc.
ANTX | NASDAQ
$4.53
-$0.16 (-3.41%)
At close: Oct 30, 2026, 4:00 PM ET
$4.53
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 5:27 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -36.28M | -34.55M | -35.17M | -33.99M | -37.38M | -45.35M | -51.32M | -60.7M | -64.66M | -66.03M | -64.73M | -59.68M | -54.31M | -48.62M | -40.96M | -36.66M | -32.26M | -27.15M | -21.54M | -14M | -7.06M | -2.05M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 414K | 414K | 414K | 414K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 4.63M | 5.66M | 6.25M | 6.63M | 7.73M | 8M | 8.34M | 8.79M | 9.06M | 8.73M | 8.41M | 7.65M | 6.71M | 6.01M | 4.39M | 3.35M | 2.48M | 1.42M | 974K | 541K | 187K | 8K |
Other Working Capital | 1.55M | -1.22M | 460K | -1.51M | -4.04M | -2.94M | -3.64M | -2.06M | -71K | 2.6M | 5.28M | 6.68M | 5.97M | 2.97M | 1.22M | -2.14M | -2M | -1.6M | -385K | 573K | -595K | 118K |
Other Non-Cash Items | -98K | -708K | -1.07M | -1.52M | -2.04M | -2.63M | -3.28M | -4.43M | -4.34M | -3.89M | -3.22M | -1.85M | -1.44M | -1.05M | -615K | -237K | 7K | 72K | 53K | 30K | 11K | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.06M | -1.68M | 164K | -991K | -3.81M | -2.3M | -3M | -5.13M | -1.32M | 1.49M | 5.83M | 10.02M | 7.49M | 5.35M | 3.72M | -1.27M | -243K | -20K | 32K | 1.94M | 57K | 497K |
Operating Cash Flow | -30.68M | -31.28M | -29.83M | -29.87M | -35.5M | -42.29M | -49.26M | -61.05M | -60.85M | -59.29M | -53.29M | -43.86M | -41.55M | -38.32M | -33.46M | -34.82M | -30.02M | -25.68M | -20.48M | -11.49M | -6.8M | -1.54M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -28.58M | -26.59M | -46.19M | -62.24M | -68.13M | -69.06M | -46.75M | -42.2M | -117.63M | -118.17M | -132.18M | -129.79M | -66.99M | -106.85M | -93.84M | -92.4M | -81.97M | -78.27M | -77.27M | -61.27M | -49.28M | n/a |
Sales Maturities Of Investments | 46.49M | 53.99M | 74.5M | 76.5M | 95M | 106.55M | 101.34M | 104.09M | 98.34M | 90.29M | 88.9M | 92.15M | 89.49M | 81.99M | 72.07M | 70.82M | 55.73M | 42.23M | 27.25M | 5M | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 17.91M | 27.41M | 28.31M | 14.26M | 26.87M | 37.49M | 54.59M | 61.89M | -19.29M | -27.88M | -43.28M | -37.64M | 22.5M | -24.86M | -21.77M | -21.58M | -26.25M | -36.05M | -50.02M | -56.27M | -49.28M | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -272K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 266K | 266K | 465K | 465K | 199K | 199K | -11K | -980K | -1.22M | -1.22M | -1.2M | -230K | 10K | 10K |
Financial Cash Flow | 38.87M | 37.38M | 113K | 113K | 88K | 88K | 372K | 51K | 66.09M | 85.14M | 84.99M | 85.32M | 19.24M | 7.37M | 70.36M | 69.39M | 69.16M | 61.98M | 78.54M | 79.5M | 79.74M | 79.74M |
Net Cash Flow | 26.1M | 33.5M | -1.41M | -15.5M | -8.55M | -4.71M | 5.7M | 888K | -14.04M | -2.02M | -11.57M | 3.81M | 196K | -55.81M | 15.12M | 12.99M | 12.89M | 248K | 8.03M | 11.74M | 23.66M | 78.2M |
Free Cash Flow | -30.68M | -31.28M | -29.83M | -29.87M | -35.5M | -42.29M | -49.26M | -61.05M | -60.85M | -59.29M | -53.29M | -43.86M | -41.55M | -38.32M | -33.46M | -34.82M | -30.02M | -25.68M | -20.48M | -11.49M | -6.8M | -1.54M |
Adj. Free Cash Flow | -35.32M | -36.94M | -36.08M | -36.5M | -43.23M | -50.29M | -57.6M | -69.84M | -69.9M | -68.01M | -61.7M | -51.51M | -48.26M | -44.33M | -37.85M | -38.17M | -32.5M | -27.1M | -21.46M | -12.03M | -6.99M | -1.55M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -30.68M | -31.28M | -29.83M | -29.87M | -35.5M | -42.29M | -49.26M | -61.05M | -60.85M | -59.29M | -53.29M | -43.86M | -41.55M | -38.32M | -33.46M | -34.82M | -30.02M | -25.68M | -20.48M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ANTX